$39.35 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest



Surmodics, Inc. is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilization reagents, substrates, surface coatings and antigens.

Stock Analysis

last close $39.35
1-mo return -1.7%
3-mo return -12.2%
avg daily vol. 42.65T
52-week high 62.27
52-week low 32.43
market cap. $513M
forward pe -
annual div. -
roe -7.6%
ltg forecast -
dividend yield -
annual rev. $97M
inst own. 92.6%

Subscribe now for daily local and international financial news